Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Amarin Corporation Plc
Amarin Secures Global Intellectual Property Rights for Lipid Programs
March 21st, 2008
Amarin Corporation plc (NASDAQ: AMRN) announced that it has signed an exclusive license with Scarista Limited ("Scarista") for the development and commercialization rights to a broad intellectual property portfolio in the field of lipid science. This intellectual property portfolio is complementary to Amarin's existing lipid-based development programs including AMR101 and its targeted lipid transport technology. The transaction consideration comprises an upfront fee to Scarista of $0.5 million and royalties upon commercialization. In 2004, Amarin licensed rights to this portfolio, covering applications in diseases of the central nervous system for North America, the EU...
Source: Health Business Week (2008-03-21)
|
